Essential oils

ApprovedSmall molecule

UUniversity of Santiago de Compostela

Essential oils is one of 76 small molecule programs targeting Vomiting. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

GingivitisActive, not recruiting

COVID-19Active, not recruiting

GrowthActive, not recruiting

GingivitisPreclinical

Active, not recruiting

COVID-19Phase 2

Active, not recruiting

GrowthApproved

Active, not recruiting

Competition

Competitive Landscape

1931 competitors in COVID-19

#DrugCompanyPhaseTrials

Essential oils

UUniversity of Santiago de Compostela

Approved

1 2

Bnt162b2

BioNTech

Preclinical

29 3

Biaxin

AbbVie

Preclinical

2 4

Singulair

AstraZeneca

Preclinical

1 5

Nitrostat

VViatris Specialty LLC

Preclinical

1 6

Low-Molecular-Weight Heparin

Daiichi Sankyo

Preclinical

3 7

Glucocorticoid

AbbVie

Preclinical

1 8

Nadroparin

GSK

Preclinical

1 9

HB-Admscs

HHope Biosciences Research Foundation

Preclinical

4 10

Biological Data

UUniversity Hospital, Bordeaux

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Growth2 trials

Antiplaque Effect of Essential Oils With and Without Alcochol on an in Situ Model of Oral Biofilm Growth

Unknown status·UUniversity of Santiago de Compostela·Phase 4·NCT02946801·20 enrolled

Antiplaque Effect of Essential Oils and 0.2% Chlorhexidine on an in Situ Model of Oral Biofilm Growth.

Completed·UUniversity of Santiago de Compostela·Phase 4·NCT02124655·15 enrolled

Alcohol2 trials

Essential Oils With and Without Alcohol: Substantivity and Antiplaque Effect

Unknown status·UUniversity of Santiago de Compostela·Phase 4·NCT03146390·20 enrolled

Immediate Effect and Substantivity of the Essential Oils Without Alcohol on the Oral Biofilm in Situ

Unknown status·UUniversity of Santiago de Compostela·Phase 4·NCT02946814·20 enrolled

Oral1 trial

Methodology Antiseptic Application, Influence on Oral Biofilm.

Unknown status·UUniversity of Santiago de Compostela·Phase 4·NCT02267239·15 enrolled

COVID-191 trial

Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients

Completed·—·Phase 2·NCT04410159·20 enrolled

Vomiting1 trial

Effect of Inhaled Aromatherapy on Chemo-Induced Nausea Vomiting (NCVI): CINVAROM (Chemotherapy Induced Nausea Vomiting and AROMatherapy)

Completed·CCentre Francois Baclesse·Phase 2·NCT04560114·96 enrolled

3 more indications

Gingivitis1 trial

Clinical Effectiveness of 5 Different Mouthwashes in the Treatment of Generalised Gingivitis

Completed·PPlovdiv Medical University·N/A·NCT04733196·180 enrolled

Treatment1 trial

Mouthwashes During Orthodontic Treatment

Unknown status·UUniversity of Taubate·Phase 4·NCT03179735·60 enrolled

Unspecified1 trial

Use of Aromatherapy to Reduce Symptom Burden

Completed·IIndiana University·Phase 2·NCT05251337·92 enrolled

Sources

References

[1]
ClinicalTrials.gov — 10 trial records for Essential oils. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Essential oils compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Essential oils. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Santiago de Compostela company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: UUniversity of Santiago de Compostela

Essential oils

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Growth2 trials

Alcohol2 trials

Oral1 trial

COVID-191 trial

Vomiting1 trial

Gingivitis1 trial

Treatment1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News